U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322991) titled 'Study to Evaluate the Drug-drug Interaction Between IY001 and IY002 in Healthy Adult Male Subjects.' on Dec. 11, 2025.
Brief Summary: The purpose of this stud is to evaluate the drug-drug interaction between IY001 and IY002 in adult males.
Study Start Date: Oct. 14, 2025
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Male
Intervention:
DRUG: IY001(Finasteride)
Subjects will receive IY001 once daily for 3 days, followed by co-administration of IY001 and IY002 once daily for 5 days.
DRUG: IY002(Tamsulosin)
Subjects will receive IY002 once daily for 5 days, followed by co-administration of IY001 and IY002 once daily for 3 ...